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BackgroundandStudyAim.Thisstudy aimedtovalidatethealarmsignsusedinthe2007GermanCEDAP-Plusstudyforindicating
capsule endoscopy in patients who have idiopathic chronic abdominal pain. Patients and Methods. We retrospectively reviewed
the cases of all patients who underwent capsule endoscopy at our institution between August 2007 and August 2009 for chronic
hithertoundiagnosedabdominalpain,despiteprevious investigations.Thedemographicdata,indications,ﬁndings,anddiagnoses
wererecorded, aswerethealarmsigns(i.e.,10%lossofweightwithin3months,suspected smallintestinalbleedorchronicanemia,
and laboratory indications of inﬂammation). Results. Alarm signs were found in only 4 of the 62 included patients. Capsule
endoscopy revealed ﬁndings that led to diagnoses ofCrohn’s disease (n = 4), tuberculosis (n = 1), gastrointestinal stromal tumors
(n = 3), and hookworm (n = 1); these diagnoses included 100% (4/4) of the patients with alarm signs, but only 8.6% (5/58)
of patients without them. However, 55.6% (5/9) of patients with clinically capsule endoscopy ﬁndings reported no alarm signs.
Conclusions. Although selecting patients based on the alarm signs may increase the yield of capsule endoscopy, the alarm sign
criteria appear to have low sensitivity.
1.Introduction
Capsule endoscopy has been unequivocally recommended as
theﬁrst linetestfor theevaluationofobscuregastrointestinal
bleed, suspected Crohn’s disease, and polyposis syndromes,
since excellent eﬀectiveness on these entities has been
conﬁrmed by many retrospective and prospective studies.
But consensus has not been achieved on the indication for
this noninvasive diagnostic modality in the evaluation of
chronic abdominal pain and diarrhea, which are among the
most common reasons referral to gastroenterologists [1].
Some studies reported that capsule endoscopy was not much
of value in patients whose symptom was chronic abdominal
painordiarrhea alone[2–4].otherstudiesfoundthatcapsule
endoscopywas helpful if chronic abdominal pain or diarrhea
was accompanied by additional alarm signs, such as weight
loss, anemia, inﬂammation, malabsorption, or obstruction
[5–7]. In the only published, prospective, multicenter trial
to date, the CEDAP-Plus study, May et al. [7]r e p o r t e dt h a t
careful selection of patients based on the presence of one
or more alarm signs might increase the diagnostic yield of
capsule endoscopy to as high as 40%. Hence the aim of
the current analysis was to validate the alarm signs used in
CEDAP-Plus study.
2.Patientsand Methods
We retrospectively reviewed the medical records of all 180
patients who had undergone diagnostic capsule endoscopy
studies at Shenzhen Nanshan Hospital between August
1, 2007 and August 30, 2009. Data extracted from the
medical records included age, sex, indication for procedure,
detailed history, physical examination, laboratory results,
and ﬁndings from previous endoscopic and radiologic tests
and abdominal ultrasonography. From 180 patients in this
group, we selected those with a history of undiagnosed
chronicabdominalpain.The admission criteriawere thatthe
abdominal pain had lasted at least 3 months, and that the
following investigations had demonstrated no abnormalities
suﬃcient to yield a diagnosis: upper and lower gastrointesti-
nal endoscopy,abdominal ultrasonography, and/orgastroin-
testinal radiology.2 ISRN Gastroenterology
The patients who met these criteria were then grouped
according to whether or not they had reported any of
the alarm signs deﬁned in the CEDAP-Plus study. These
included (1) weight loss of ≥10% within 3 months
(2) chronic suspected mid-gastrointestinal bleeding and/or
chronic iron-deﬁciency anemia for 3 months or more,
with hemoglobin levels ≤11g/dL for women and 13g/dL
for men and (3) pathology laboratory results suggesting
inﬂammation, such as erythrocyte sedimentation rate (ESR)
>15/30mm/h,Westergrenmethod;C-reactiveprotein(CRP)
>2ng/dL;thrombocytosis>400000/mL, and/or leukocytosis
>15000/mL.
All patients gave informed consent prior to capsule
endoscopy (OMOM Capsule Endoscope System, Jinshan,
China). A polyethylene glycol (2L) and simethicone prepa-
ration was administered the day before the procedure, and
the video capsule ingested after an overnight fast. Patients
were allowed to drink clear ﬂuids 2h after swallowing the
capsule and to consume a light meal 4h after ingestion.
They returned the recording system approximately 8h after
having swallowed the video capsule. The data recorder was
subsequently downloaded to a workstation and the video
analyzed by a gastroenterologist proﬁcient in the technique.
Intestinal preparation for capsule endoscopy was deﬁned
as excellent (no debris, completely visualization of the
mucosa), good (some debris), fair (several areas with incom-
plete visualization), or poor (large amounts of debris that
compromised results).
Lesions found on capsule endoscopy were classiﬁed
according to whether or not they could explain the patient’s
symptoms. Signiﬁcant ﬁndings included multiple erosions
or ulcerations, diﬀuse erythema and edema, mucosal
atrophy, strictures, tumors, diﬀuse lymphangiectasia, an
inﬂamed secondary diverticulum or Meckel’s diverticulum,
and intestinal worms. Lesions considered not signiﬁcant
includedarteriovenousmalformations, focallymphangiecta-
sia, hyperplastic follicles, small lipomas, solitary diverticuli,
focal erythema, or scattered and small mucosal erosions or
breaks.
Descriptive statistics were used to report the demo-
graphics and clinical characteristics of patients. We reported
the prevalence of ﬁndings, the complete visualization, and
incidence of retention of the capsule. Statistical uncertainty
was quantiﬁed by calculating 95% conﬁdence intervals (CIs)
usingthebinomialmethod.Fisher’s test wasusedtocompare
diagnostic yield diﬀerence between the patients with and
without the alarm signs deﬁned by the CEDAP-Plus study.
Both the patients and the Hospital Ethics Committee agreed
on our research.
3.Results
Overthe24-monthstudyperiod,62patientswereconsidered
to have obscure chronic abdominal pain and were included
in the study. Of these, 51 had chronic diarrhea, 6 had
constipation, and 5 reported normal bowel movements. The
median age was 43 years (range 20–78), and there were 27
malesand 35females(43.5and56.5%,resp.).Only4patients
h a da l a r ms i g n sa sd e ﬁ n e db yt h eC E D A P - P l u sS t u d y .
Visualization of the entire small bowel with cecum was
achieved in 61 of the 62 patients (98.0%, 95% CI = 91.4–
100%).Preparationforcapsuleendoscopywasexcellentin40
patients (64.5%), good in 21 (33.8%), and fair in 1 (1.6%).
Of the 62 patients, capsule endoscopy revealed clinically
s i g n i ﬁ c a n tﬁ n d i n g st h a tw e r ea b l et oe x p l a i nt h ep a t i e n t ’ s
symptoms in 9 cases (diagnostic yield, 14.5%; 95% CI =
6.9–25.8%). The ﬁnal diagnoses of these patients included
Crohn’s disease in 4 patients, tuberculous peritonitis in 1,
gastrointestinal stromal tumors (GISTs) in 3, and hookworm
in 1. A total of 16 patients (25.8%, 95% CI = 11.5–38.5%)
had lesions not related to their symptoms, including arteri-
ovenous malformation in 3 patients, focal lymphangiectasia
in 4, hyperplasic follicle in 5, solitary diverticulum in 1, focal
erythema or red spots in 3, and a few small mucosal erosions
or breaks in 2.
Alarm signs were present in 4 of the 62 patients. These
included weight loss in a patient with Crohn’s disease,
anemia in a patient with hookworm, both weight loss and
anemia in a patient with middle grade malignant GISTs, and
an elevated ESR in a patient with tuberculous peritonitis.
All 4 patients who had alarm signs had clinically signiﬁcant
ﬁndings (100%, 95% CI = 40–100%). In contrast, of the 58
patients without alarm signs, only 5 had clinically signiﬁcant
ﬁndings (8.6%, 95% CI = 2.9–19.0%). This diﬀerence be-
tween the 2 groups was statistically signiﬁcant (Fisher’s exact
test, P = .000).
Of the 9 patients with clinically signiﬁcant ﬁndings on
capsule endoscopy, 5 patients (55.6%) had none of the alarm
signs deﬁned by the CEDAP-Plus study (95% CI = 21.2–
86.3%). These included 3 patients with Crohn’s disease and
2 patients with low-grade malignant GISTs.
4.Discussion
The introduction of capsule endoscopy into the ﬁeld of
small-bowel diseases diagnosis made deﬁnition of indi-
cations mandatory on the basis of published data, with
suspected mid-gastrointestinal bleeding being the most
suitable indication for the procedure. Published reports
have described diagnostic yields in the range of 48–76%
with this indication. Other potential indications for capsule
endoscopy included suspected Crohn’s disease, and poly-
posis syndromes such as familial adenomatosis or Peutz-
Jeghers syndrome. Treatment-refractory celiac disease is
also conceivably an indication. However, the beneﬁts of
capsule endoscopy during diagnostic work-up for chronic
abdominal pain and/or diarrhea, the most common reasons
referral to gastroenterologists, have remained unclear or
controversial [1]. For example, Bardan et al. [2]i n v e s t i g a t e d
the yield of capsule endoscopy in 20 patients who suﬀered
fromchronicabdominalpainandwasinnocaseabletomake
a diagnosis capable of explaining the patient’s symptoms.
Spada et al. [3] used capsule endoscopy to evaluate a
cohort of 16 patients with chronic abdominal pain, and
only in 1 case obtained a ﬁnding correlated with clinical
symptoms (6.3%). A retrospective analysis by Fry et al. [4]
reported a slightly higher diagnostic yield (9%, 6/64) usingISRN Gastroenterology 3
capsule endoscopy in patients with chronic abdominal pain
or diarrhea. In this retrospective study, we investigated the
diagnostic yield of capsule endoscopy in 62 patients with
obscure chronic abdominal pain, and found that there were
clinically signiﬁcant ﬁndings in only 14.5% of these patients
(9/62). Although this represents a relatively low diagnostic
yield, it is higher than that of the previous reports and
suggeststhat capsuleendoscopyshould at least be considered
during the diagnostic work-up for the chronic abdominal
pain.
One way to increase the diagnostic yield of capsule
endoscopy in the case of chronic abdominal pain is to
preselect patients based on other criteria. In an early
retrospective study, Shim et al. [5] analyzed clinical ﬁndings
in 110 patients and found that capsule endoscopy was
helpful, with a diagnostic yield of 17%, in patients whose
abdominal pain was accompanied with weight loss or
elevated serum markers of inﬂammation. The results of
a similar study showed that the presence of concomitant
signs of inﬂammation, malabsorption, or obstruction were
a predictive factor for positive capsule endoscopy ﬁndings
in patients with abdominal pain, with or without diarrhea
[6]. In the only published, prospective, multicenter trial to
date, the CEDAP-Plus study [7], May et al. reported that
careful selection of patients based on the presence of one
or more alarm signs might increase the diagnostic yield
of capsule endoscopy to as high as 40%. The results of
the present study support these observations. Speciﬁcally,
whereas all 4 patients who had the alarm signs speciﬁed in
the CEDAP-Plus Study had clinically signiﬁcant ﬁndings on
capsule endoscopy, signiﬁcant ﬁndings were found in only 5
of 58 patients without these alarm signs.
It is important to note that the absence of alarm signs
does not indicate that capsule endoscopy is unlikely to
result in clinically signiﬁcant ﬁndings in these patients.
In the current study, 5 of the 9 patients with signiﬁcant
endoscopic ﬁndings had no history of any of the CEDAP-
Plusalarmsigns.Thus,ifpatientshadbeenprescreened,with
the presence of alarm signs being an absolute requirement
for eligibility for capsule endoscopy, 55% of patients in
which this technique was potentially useful would have been
missed. These results suggest that the alarm signs deﬁned by
the CEDAP-Plus study are of relatively low sensitivity in this
group of patients.
In conclusion, patient selection on the basis of alarm
signs may increase the yield of capsule endoscopy in patients
with obscure chronic abdominal pain. However, as the
alarm-sign criteria deﬁed by the CEDAP-Plus Study appear
to be of low sensitivity, future research should concentrate
on uncovering new and more sensitive screening criteria.
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